Adashek, Jacob J.
Kato, Shumei
Lippman, Scott M.
Kurzrock, Razelle
Article History
Received: 26 September 2019
Accepted: 30 January 2020
First Online: 17 February 2020
Competing interests
: JJA and SML declare that they have no competing interests. SK serves as a consultant for Foundation Medicine. RK has received research funding from Incyte, Genentech, Merck Serono, Pfizer, Sequenom, Foundation Medicine, Guardant Health, Grifols, and Konica Minolta, as well as consultant fees from LOXO, X-Biotech, Actuate Therapeutics, Genentech, and NeoMed. She receives speaker fees from Roche and has an equity interest in IDbyDNA and Curematch, Inc.